Synthesis of Cyclo-1,3-dien-5-ynes
4378±4385
the remaining yellow oil was purified by column chromatography on silica
gel (pentane/ether 2:1, v/v). The dialdehydes 12 were obtained as
colorless, unstable oils, which did not give satisfactory elemental analyses.
158.8 (C-3), 177.2 (C-14), 194.1 (C-1); IR (film): nÄ 2930 (vs), 2857 (s), 2280
(w), 2236 (w), 2201 (m), 1691 (vs), 1670 (vs), 1466 (m), 1422 (m), 1283 (m),
1231 (m), 1139 (m), 977 cm 1 (m); UV/Vis (MeCN): lmax(lg e) 220 (4.00),
246 nm (3.04, sh).
Dec-2-en-8-ynedial (12a): This compound was prepared according to the
general procedure: 11a (3.2 g, 17.8 mmol), nBuLi (1.6m, 11.3 mL,
18.1 mmol), DMF (1.64 g, 22.5 mmol), and H2SO4 (96%, 4.4 g) in ice
water (90 mL) provided 12a (2.07 g, 12.6 mmol, 71%). 1H NMR (200 MHz,
CDCl3): d 1.58 ± 1.71 (m, 4H; 5-H, 6-H), 2.30 ± 2.47 (m, 4H; 4-H, 7-H),
6.10 (ddt, 3J 15.6, 3J 7.9, 4J 1.5 Hz, 1H; 2-H), 6.81 (dt, 3J 6.7, 3J
15.6 Hz, 1H; 3-H), 9.15 (t, 5J 0.8 Hz, 1H; 10-H), 9.48 (d, 3J 7.9 Hz, 1H;
1-H); 13C NMR (50.3 MHz, CDCl3): d 18.9 (C-7), 26.8, 26.9 (C-5, C-6),
32.0 (C-4), 81.9 (C-9), 98.0 (C-8), 133.3 (C-2), 157.4 (C-3), 177.0 (C-10),
193.8 (C-1); IR (film): nÄ 2943 (s), 2866 (s), 2281 (s), 2236 (s), 2203 (s),
1694 (vs), 1691 (vs), 1463 (m), 1418 (s), 1396 (s), 1355 (s), 1286 (s), 1243 (s),
1210 (s), 1138 (s), 1088 (m), 1077 (m), 1021 (m), 981 (s), 905 cm 1 (m); UV/
Vis (MeCN): lmax(lg e) 218 (4.03), 230 (3.86, sh), 244 nm (3.12, sh).
General procedure for the preparation of the cyclo-1,3-dien-5-ynes 6: A
flame-dried three-necked flask (1 L) was charged under argon with
TiCl3(DME)1.5 , prepared according to [21], and with a zinc/copper couple.
The two components were mixed thoroughly. Freshly distilled DME was
added, and the mixture was heated under reflux for 5 h, during which time
it turned black. The suspension was cooled to room temperature, and a
solution of the bisaldehyde 12 in DME (20 mL) was added slowly by means
of a motor-driven syringe (ca. 30 h). The reaction mixture was stirred until
the substrate 12 had been consumed completely, while the process was
monitored by GC analysis. After dilution with pentane (250 mL), the
product mixture was filtered through silica gel, and the column was washed
carefully with pentane. The organic solvents were removed in vacuo, and
the remaining oil was purified by preparative thick-layer chromatography
on silica gel with pentane. The cyclodienynes 6 were isolated as colorless
oils. In all cases the volatile products contained varying amounts of solvent
(DME, as shown by 1H NMR analysis); this made the determination of
elemental analyses impossible.
Undec-2-en-9-ynedial (12b): This compound was prepared according to the
general procedure: 11b (4.4 g, 22.7 mmol), nBuLi (1.6m, 14.7 mL,
23.5 mmol), DMF (2.1 g, 28.8 mmol), and H2SO4 (96%, 5.0 g) in ice water
(100 mL) provided 12b (1.66 g, 9.33 mmol, 41%). 1H NMR (200 MHz,
CDCl3): d 1.39 ± 1.67 (m, 6H; 5-H, 6-H, 7-H), 2.21 ± 2.62 (m, 4H; 4-H,
8-H), 5.78 ± 6.16 (m, 1H; 2-H), 6.76 ± 7.10 (m, 1H; 3-H), 9.14 (t, 5J 0.8 Hz,
1H; 11-H), 9.46 (d, 3J 7.9 Hz, 1H; 1-H); 13C NMR (50.3 MHz, CDCl3):
d 18.5 (C-8), 27.2 (2 signals), 28.2 (C-5, C-6, C-7), 32.4 (C-4), 81.8 (C-10),
98.7 (C-9), 133.0 (C-2), 158.4 (C-3), 177.2 (C-11), 194.2 (C-1); IR (film): nÄ
3022 (m), 2937 (vs), 2863 (s), 2281 (w), 2235 (m), 2202 (s), 1692 (vs), 1670
(vs), 1458 (m), 1426 (m), 1390 (m), 1373 (m), 1236 (s), 1168 (m), 1139 (s),
Cyclodeca-1,3-dien-5-yne (6a): This compound was prepared according to
the general procedure: TiCl3(DME)1.5 (13.0 g, 44.9 mmol), Zn/Cu couple
(17.1 g, 0.27 mol), and 12a (1.6 g, 9.78 mmol) in DME (220 mL) provided
6a (60 mg, 0.45 mmol, 5%). 1H NMR (200 MHz, CDCl3): d 1.71 (m, 4H;
3
8-H, 9-H), 2.10 (m, 2H; 10-H), 2.18 (m, 2H; 7-H), 5.28 (dm, J 10.2 Hz,
3
1H; 4-H), 5.53 (dm, J 15.9 Hz, 1H; 2-H), 6.31 (m, 1H; 1-H), 6.41 (dm,
1
1093 (m), 1072 (m), 1017 (m), 979 (m), 756 cm (m); UV/Vis (MeCN):
3J 10.2 Hz, 1H; 3-H); 13C NMR (50.3 MHz, CDCl3): d 21.9 (C-7), 26.9,
30.8 (C-8, C-9), 33.0 (C-10), 84.1 (C-5), 97.5 (C-6), 112.0 (C-4), 123.1 (C-2),
141.8 (C-1), 142.6 (C-3); IR (film): nÄ 2934 (vs), 2864 (s), 2251 (w), 2205
(w), 1720 (vs), 1679 (vs), 1449 (m), 1408 (m), 1392 (m), 1351 (m), 1326 (m),
1260 (m), 1232 (m), 1212 (m), 1167 (m), 1140 (m), 1099 (m), 1079 (m), 1031
(m), 1013 (m), 914 (m), 733 (s), 647 cm 1 (m); UV/Vis (MeCN): lmax(lg e)
lmax(lg e) 218 nm (3.93); MS (70 eV, EI): m/z (%): 178 [M] (1), 177 (2),
149 (20), 135 (32), 121 (46), 107 (72), 91 (68), 79 (100), 67 (43), 55 (89).
Dodec-2-en-10-ynedial (12c): This compound was prepared according to
the general procedure: 11c (3.0 g, 14.4 mmol), nBuLi (1.6m, 9.1 mL,
14.6 mmol), DMF (1.33 g, 18.2 mmol), and H2SO4 (96%, 2.5 g) in ice water
(65 mL) provided 12c (2.39 g, 12.4 mmol, 86%). 1H NMR (200 MHz,
CDCl3): d 1.30 ± 1.60 (m, 8H; 5-H to 8-H), 2.31 (pseudo qd, 3J 7.1, 3J
7.1, 4J 1.5 Hz, 2H; 4-H), 2.38 (dt, 3J 6.9, 5J 0.8 Hz, 2H; 9-H), 6.07 (ddt,
3J 15.7, 3J 7.9, 4J 1.5 Hz, 1H; 2-H), 6.81 (dt, 3J 6.9, 3J 15.6, 1H;
3-H), 9.13 (brs, 1H; 12-H), 9.46 (d, 3J 7.9 Hz, 1H; 1-H); 13C NMR
(50.3 MHz, CDCl3): d 19.0 (C-9), 27.3, 27.5, 28.4, 28.5 (C-5 to C-8), 32.5
(C-4), 81.7 (C-10), 98.9 (C-11), 133.0 (C-2), 158.5 (C-3), 177.1 (C-12), 194.0
(C-1); IR (film): nÄ 2935 (vs), 2860 (s), 2280 (w), 2235 (w), 2201 (s), 1690
192 (3.94), 212 (3.52, sh), 226 nm (3.29); MS (GC/MS): m/z (%): 132 [M]
(80), 115 (24), 104 (100), 91 (65), 78 (17), 65 (16).
Cycloundeca-1,3-dien-5-yne (6b): This compound was prepared according
to the general procedure: TiCl3(DME)1.5 (5.2 g, 17.9 mmol), Zn/Cu couple
(3.8 g, 58 mmol), and 12b (0.4 g, 2.2 mmol) in DME (220 mL) provided 6b
(121 mg, 0.83 mmol, 38%). 1H NMR (200 MHz, CDCl3): d 1.34 (m, 2H;
10-H), 1.49 (m, 2H; 8-H), 1.60 (m, 2H; 9-H), 2.08 (m, 2H; 11-H), 2.28 (m,
2H; 7-H), 5.34 (dm, 3J 10.6 Hz, 1H; 4-H), 5.61 (dm, 3J 15.7 Hz, 1H;
2-H), 5.87 (m, 1H; 1-H), 6.33 (dm, 3J 10.5 Hz, 1H; 3-H); 13C NMR
(50.3 MHz, CDCl3): d 17.7 (C-7), 22.0 (C-9), 23.9 (C-10), 26.4 (C-8), 32.2
(C-11), 82.8 (C-5), 93.5 (C-6), 111.2 (C-4), 125.6 (C-2), 137.9 (C-1), 140.9
(C-3); IR (film): nÄ 3018 (m), 2929 (vs), 2860 (s), 2219 (w), 2205 (w), 2170
(w), 1682 (s), 1648 (m), 1456 (m), 1443 (m), 1346 (m), 1018 (m), 968 (m),
921 (m), 765 cm 1 (m); UV/Vis (MeCN): lmax(lg e) 198 (3.77), 242 (3.56),
1
(vs), 1670 (vs), 1464 (w), 1448 (s), 1390 (w), 1159 (m), 1138 (m), 978 cm
(m); UV/Vis (MeCN): lmax(lg e) 220 (4.14), 248 (3.11, sh), 266 nm (2.78,
sh); MS (70 eV, EI): m/z (%): 193 [MH] (5), 192 [M] (1), 191 (4), 173
(4), 161 (19), 149 (21), 133 (36), 135 (36), 121 (52), 107 (51), 91 (67), 81
(100), 67 (57), 55 (75); HRMS: m/z calcd for C12H16O2 192.1150; found
192.1150.
268 nm (3.52); MS (GC/MS): m/z (%): 146 [M] (5), 145 (6), 131 (28), 117
Tridec-2-en-11-ynedial (12d): This compound was prepared according to
the general procedure: 11d (2.7 g, 12.2 mmol), nBuLi (1.6m, 7.9 mL,
12.7 mmol), DMF (1.13 g, 15.5 mmol), and H2SO4 (3.0 g, 96%) in ice water
(60 mL) provided 12d (1.57 g, 7.63 mmol, 63%). 1H NMR (200 MHz,
CDCl3): d 1.18 ± 1.57 (m, 10H; 5-H to 9-H), 2.22 ± 2.64 (m, 4H; 4-H,
10-H), 5.73 ± 6.15 (m, 1H; 2-H), 6.55 ± 6.97 (m, 1H; 3-H), 9.15 (t, 5J
0.8 Hz, 1H; 13-H), 9.48 (d, 3J 7.9 Hz, 1H; 1-H); 13C NMR (50.3 MHz,
CDCl3): d 19.0 (C-10), 27.4, 27.7, 28.6, 28.7, 28.9 (C-5 to C-9), 32.6 (C-4),
81.7 (C-12), 99.2 (C-11), 132.9 (C-2), 158.9 (C-3), 177.2 (C-13), 194.3 (C-1);
IR (film): nÄ 2932 (vs), 2858 (s), 2281 (w), 2235 (m), 2201 (s), 1690 (vs),
1670 (vs), 1465 (m), 1423 (m), 1283 (m), 1235 (m), 1139 (m), 976 cm 1 (m);
UV/Vis (MeCN): lmax(lg e) 222 nm (4.18), 248 (3.03, sh); MS (70 eV, EI):
(100), 104 (36), 91 (66), 78 (28), 65 (15).
Cyclododeca-1,3-dien-5-yne (6c): This compound was prepared according
to the general procedure: TiCl3(DME)1.5 (11.0 g, 37.9 mmol), Zn/Cu couple
(14.6 g 0.22 mol), and 12c (1.6 g, 8.33 mmol) in DME (220 mL) provided 6c
1
(210 mg, 1.31 mmol, 16%). H NMR (200 MHz, CDCl3): d 1.47 (m, 6H;
8-H, 9-H, 10-H), 1.60 (m, 2H; 11-H), 2.11 (m, 2H; 12-H), 2.21 (m, 2H;
7-H), 5.34 (d, 3J 11.0 Hz, 1H; 4-H), 5.75 (dm, 3J 15.8 Hz, 1H; 2-H), 6.10
(dm, 3J 11.0 Hz, 1H; 3-H), 6.41 (dm, 3J 15.8 Hz, 1H; 1-H); 13C NMR
(50.3 MHz, CDCl3): d 19.7 (C-7), 25.6, 25.7, 27.1, 27.2, 32.4 (C-8 to C-12),
80.7 (C-5), 94.8 (C-6), 108.8 (C-4), 125.1 (C-2), 138.4 (C-1), 138.6 (C-3); IR
(film): nÄ 2927 (vs), 2858 (s), 2208 (w), 1712 (m), 1683 (m), 1656 (m), 1459
(m), 1445 (m), 1348 (m), 1320 (m), 1132 (m), 1117 (m), 1110 (m), 1091 (m),
m/z (%): 205 [M H] (1), 204 (1), 183 (6), 171 (5), 159 (4), 145 (8), 131
1
(100), 117 (84), 91 (79), 79 (36), 67 (28).
1050 (m), 1024 (m), 970 (m), 911 (m), 733 cm (m); UV/Vis (MeCN):
lmax(lg e) 244 (3.54), 264 nm (3.55); MS (GC/MS): m/z (%): 160 [M] (6),
Tetradec-2-en-12-ynedial (12e): This compound was prepared according to
the general procedure: 11e (0.52 g, 2.2 mmol), nBuLi (1.6m, 1.4 mL,
2.2 mmol), DMF (0.20 g, 2.76 mmol), and H2SO4 (96%, 0.4 g) in ice water
(10 mL) provided 12e (234 mg, 1.06 mmol, 48%). 1H NMR (200 MHz,
CDCl3): d 1.31 ± 1.83 (m, 12H; 5-H to 10-H), 2.26 ± 2.58 (m, 4H; 4-H, 11-
H), 6.10 (ddt, 3J 15.6, 3J 7.9, 4J 1.5 Hz, 1H; 2-H), 6.84 (dt, 3J 6.8, 3J
15.6 Hz, 1H; 3-H), 9.16 (t, 5J 0.8 Hz, 1H; 14-H), 9.50 (d, 3J 7.9 Hz, 1H;
1-H); 13C NMR (50.3 MHz, CDCl3): d 19.1 (C-11), 27.4, 27.7, 28.7, 28.8,
29.0, 29.1 (C-5 to C-10), 32.6 (C-4), 81.7 (C-13), 99.2 (C-12), 133.0 (C-2),
145 (7), 131 (39), 117 (100), 104 (27), 91 (91), 79 (41), 65 (17).
Cyclotrideca-1,3-dien-5-yne (6d): This compound was prepared according
to the general procedure: TiCl3(DME)1.5 (5.74 g, 19.8 mmol), Zn/Cu couple
(4.19 g, 64 mmol), and 12d (0.5 g, 2.43 mmol) in DME (150 mL) provided
6d (156 mg, 0.90 mmol, 37%). 1H NMR (200 MHz, CDCl3): d 1.13 ± 1.57
(m, 10H; 8-H to 12-H), 2.13 ± 2.49 (m, 4H; 7-H, 13-H), 5.22 (dm, 3J
10.1 Hz, 1H; 4-H), 5.99 ± 6.85 (m, 3H; 1-H, 2-H, 3-H); 13C NMR
(50.3 MHz, CDCl3): d 19.9 (C-7), 25.4, 25.7, 26.1, 27.6, 29.1, 30.1 (C-8 to
Chem. Eur. J. 2001, 7, No. 20
ꢁ WILEY-VCH Verlag GmbH, D-69451 Weinheim, 2001
0947-6539/01/0720-4383 $ 17.50+.50/0
4383